讀客文化(301025.SZ):終止向不特定對象發行可轉換公司債券
格隆匯2月18日丨讀客文化(301025.SZ)公佈,公司於2025年2月18日分別召開第三屆董事會第八次會議及第三屆監事會第五次會議,審議通過了《關於終止公司向不特定對象發行可轉換公司債券的議案》,同意公司終止本次向不特定對象發行可轉換公司債券(以下簡稱“本次可轉債發行”)的事項。
自本次公司向不特定對象發行可轉換公司債券預案披露以來,公司董事會、經營管理層與中介機構一直積極有序推進各項相關工作,綜合考慮外部環境變化、公司戰略發展規劃等因素,經審慎分析並與中介機構充分溝通論證後,公司決定終止本次可轉債發行事項。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.